Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Mar 1, 2018)
  • 8-K (Feb 6, 2018)
  • 8-K (Jan 9, 2018)
  • 8-K (Dec 19, 2017)
  • 8-K (Nov 13, 2017)
  • 8-K (Nov 2, 2017)

 
Other

Nanometrics 8-K 2018

Documents found in this filing:

  1. 8-K
  2. 8-K
nano-8k_20180109.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D. C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (date of earliest event reported): January 8, 2018

Nanometrics Incorporated

(Exact name of Registrant as specified in its charter)

 

Delaware

 

000-13470

 

94-2276314

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I. R. S. Employer

Identification No.)

1550 Buckeye Drive, Milpitas, California 95035

(Address of principal executive offices and zip code)

Registrant's telephone number, including area code: (408) 545-6000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933

(17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for

complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 



 

Item 5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

On January 8, 2018, Nanometrics Incorporated and S. Mark Borowicz, Nanometrics’ Executive Vice President, Business Operations, agreed that Dr. Borowicz would cease to be an officer and employee of Nanometrics effective January 9, 2018.  In connection with this determination, on January 8, 2018, Nanometrics and Dr. Borowicz entered into a severance and separation agreement pursuant to which Dr. Borowicz will receive:  a severance payment of $155,000.00; COBRA premiums payable by the Company for Dr. Borowicz and his covered dependents until July 31, 2018; and a target bonus, under Nanometrics’ 2017 Executive Performance Bonus Plan (the “Plan”), of $186,000.00 (subject to increase in the event the Compensation Committee determines he is entitled to an amount higher than the executive bonus based on the criteria set forth in the Plan).  In addition, the agreement provides that vesting of restricted stock units and performance shares held by Dr. Borowicz will cease as of the February 28, 2018, and that Nanometrics and Dr. Borowicz will enter into an independent contractor agreement.  

On January 9, 2018, Nanometrics and Dr. Borowicz entered into the independent contractor agreement with a term ending on February 28, 2018, pursuant to which Dr. Borowicz will render to Nanometrics transition services for operations and engineering, as required, and be paid compensation of $6,000 every two weeks during the term of the consulting period.

 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 9, 2018

 

NANOMETRICS INCORPORATED

 

 

 

By:

/s/    Janet Taylor

 

 

Janet Taylor

 

 

General Counsel

 

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki